Literature DB >> 23071088

MBD2 and multiple domains of CHD4 are required for transcriptional repression by Mi-2/NuRD complexes.

Julita Ramírez1, Carissa Dege, Tatiana G Kutateladze, James Hagman.   

Abstract

Mi-2/nucleosome remodeling and deacetylase (NuRD) chromatin remodeling complexes are important regulators of chromatin structure and DNA accessibility. We examined requirements for individual domains of chromodomain helicase DNA-binding protein 4 (CHD4), a core catalytic component of NuRD complexes, as well as the NuRD subunit methyl-binding domain protein 2 (MBD2) and methylated DNA, for NuRD function in the context of tissue-specific transcription. By itself, loss of NuRD activity is not sufficient for transcriptional activation. However, NuRD complexes greatly reduce activation of the B cell-specific mb-1 (Cd79a) gene by the transcription factors EBF1 and Pax5. Using our B cell model system, we determined that the two chromodomains and ATPase/helicase and C-terminal domains (CTD) of CHD4 are all necessary for repression of mb-1 promoters by NuRD. All of these domains except the CTD are required for efficient association of CHD4 with mb-1 promoter chromatin. Loss of MBD2 expression or of DNA methylation impaired association of CHD4 with mb-1 promoter chromatin and enhanced its transcription. We conclude that repressive functions of MBD2-containing NuRD complexes are dependent on cooperative interactions between the major domains of CHD4 with histones and DNA and on binding of methylated DNA by MBD2.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23071088      PMCID: PMC3510529          DOI: 10.1128/MCB.00819-12

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.

Authors:  F Magdinier; A P Wolffe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

2.  Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter.

Authors:  T Agalioti; S Lomvardas; B Parekh; J Yie; T Maniatis; D Thanos
Journal:  Cell       Date:  2000-11-10       Impact factor: 41.582

3.  The dMi-2 chromodomains are DNA binding modules important for ATP-dependent nucleosome mobilization.

Authors:  Karim Bouazoune; Angelika Mitterweger; Gernot Längst; Axel Imhof; Asifa Akhtar; Peter B Becker; Alexander Brehm
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

4.  CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system.

Authors:  Patricia M Thompson; Takahiro Gotoh; Marleen Kok; Peter S White; Garrett M Brodeur
Journal:  Oncogene       Date:  2003-02-20       Impact factor: 9.867

5.  The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2.

Authors:  Motoki Saito; Fuyuki Ishikawa
Journal:  J Biol Chem       Date:  2002-07-17       Impact factor: 5.157

Review 6.  NuRD and pluripotency: a complex balancing act.

Authors:  Guang Hu; Paul A Wade
Journal:  Cell Stem Cell       Date:  2012-05-04       Impact factor: 24.633

7.  Gene silencing quantitatively controls the function of a developmental trans-activator.

Authors:  Anne S Hutchins; Alan C Mullen; Hubert W Lee; Kara J Sykes; Frances A High; Brian D Hendrich; Adrian P Bird; Steven L Reiner
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

8.  Concerted action of the PHD, chromo and motor domains regulates the human chromatin remodelling ATPase CHD4.

Authors:  Rosa Morra; Benjamin M Lee; Heather Shaw; Roman Tuma; Erika J Mancini
Journal:  FEBS Lett       Date:  2012-06-27       Impact factor: 4.124

9.  NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment.

Authors:  Nicola Reynolds; Paulina Latos; Antony Hynes-Allen; Remco Loos; Donna Leaford; Aoife O'Shaughnessy; Olukunbi Mosaku; Jason Signolet; Philip Brennecke; Tüzer Kalkan; Ita Costello; Peter Humphreys; William Mansfield; Kentaro Nakagawa; John Strouboulis; Axel Behrens; Paul Bertone; Brian Hendrich
Journal:  Cell Stem Cell       Date:  2012-05-04       Impact factor: 24.633

10.  The PHD and chromo domains regulate the ATPase activity of the human chromatin remodeler CHD4.

Authors:  Aleksandra A Watson; Pravin Mahajan; Haydyn D T Mertens; Michael J Deery; Wenchao Zhang; Peter Pham; Xiuxia Du; Till Bartke; Wei Zhang; Christian Edlich; Georgina Berridge; Yun Chen; Nicola A Burgess-Brown; Tony Kouzarides; Nicola Wiechens; Tom Owen-Hughes; Dmitri I Svergun; Opher Gileadi; Ernest D Laue
Journal:  J Mol Biol       Date:  2012-05-07       Impact factor: 5.469

View more
  27 in total

Review 1.  An evolving understanding of nuclear receptor coregulator proteins.

Authors:  Christopher J Millard; Peter J Watson; Louise Fairall; John W R Schwabe
Journal:  J Mol Endocrinol       Date:  2013-11-07       Impact factor: 5.098

Review 2.  Architects of the genome: CHD dysfunction in cancer, developmental disorders and neurological syndromes.

Authors:  Wangzhi Li; Alea A Mills
Journal:  Epigenomics       Date:  2014       Impact factor: 4.778

Review 3.  Interpreting the language of histone and DNA modifications.

Authors:  Scott B Rothbart; Brian D Strahl
Journal:  Biochim Biophys Acta       Date:  2014-03-12

Review 4.  Mi-2/NuRD chromatin remodeling complexes regulate B and T-lymphocyte development and function.

Authors:  Carissa Dege; James Hagman
Journal:  Immunol Rev       Date:  2014-09       Impact factor: 12.988

5.  Poly(ADP-ribose)-dependent chromatin unfolding facilitates the association of DNA-binding proteins with DNA at sites of damage.

Authors:  Rebecca Smith; Théo Lebeaupin; Szilvia Juhász; Catherine Chapuis; Ostiane D'Augustin; Stéphanie Dutertre; Peter Burkovics; Christian Biertümpfel; Gyula Timinszky; Sébastien Huet
Journal:  Nucleic Acids Res       Date:  2019-12-02       Impact factor: 16.971

6.  The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complex.

Authors:  Venkatadri Kolla; Koumudi Naraparaju; Tiangang Zhuang; Mayumi Higashi; Sriharsha Kolla; Gerd A Blobel; Garrett M Brodeur
Journal:  Biochem J       Date:  2015-06-01       Impact factor: 3.857

7.  Muscles cannot break a NuRDy heart.

Authors:  Barbora Malecova; Alessandra Dall'Agnese; Pier Lorenzo Puri
Journal:  EMBO J       Date:  2016-06-14       Impact factor: 11.598

8.  DLX1 and the NuRD complex cooperate in enhancer decommissioning and transcriptional repression.

Authors:  James D Price; Susan Lindtner; Athena Ypsilanti; Fadya Binyameen; Jeffrey R Johnson; Billy W Newton; Nevan J Krogan; John L R Rubenstein
Journal:  Development       Date:  2022-06-13       Impact factor: 6.862

Review 9.  The NuRD architecture.

Authors:  Hillary F Allen; Paul A Wade; Tatiana G Kutateladze
Journal:  Cell Mol Life Sci       Date:  2013-01-23       Impact factor: 9.261

10.  Covalent Modifications of Histone H3K9 Promote Binding of CHD3.

Authors:  Adam H Tencer; Khan L Cox; Luo Di; Joseph B Bridgers; Jie Lyu; Xiaodong Wang; Jennifer K Sims; Tyler M Weaver; Hillary F Allen; Yi Zhang; Jovylyn Gatchalian; Michael A Darcy; Matthew D Gibson; Jinzen Ikebe; Wei Li; Paul A Wade; Jeffrey J Hayes; Brian D Strahl; Hidetoshi Kono; Michael G Poirier; Catherine A Musselman; Tatiana G Kutateladze
Journal:  Cell Rep       Date:  2017-10-10       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.